0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study.

      1 , 2 , 3 , 3 , 4 , 4 , 5 , 5 , 6 , 6 , 7 , 7 , 7 , 8 , 8 , 9 , 9 , 10 , 11 , 11 , 12 , 12 , 13 , 13 , 14 , 15 , 15 , 16 , 17 , 18 , 17 , 1 , 1 , 19 , 17
      Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
      Elsevier BV
      Adjuvant therapy, Localized prostate cancer, Prognostic parameters, Surgical margins

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Positive surgical margins (PSM) after radical prostatectomy have been shown to be associated with impaired outcome. In pT3pN0 patients with PSM either immediate radiotherapy or clinical and biological monitoring followed by salvage radiotherapy is recommended by the latest guidelines of the European Association of Urology.

          Related collections

          Author and article information

          Journal
          Radiother Oncol
          Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
          Elsevier BV
          1879-0887
          0167-8140
          Jul 2015
          : 116
          : 1
          Affiliations
          [1 ] Ludwig-Maximilians-University, Dept. of Urology, Munich, Germany.
          [2 ] Ludwig-Maximilians-University, Dept. of Urology, Munich, Germany. Electronic address: alexander.buchner@med.uni-muenchen.de.
          [3 ] Ludwig-Maximilians-University, Dept. of Pathology, Munich, Germany.
          [4 ] Ludwig-Maximilians-University, Dept. of Radiation Oncology, Munich, Germany.
          [5 ] University Regensburg, Dept. of Urology, Germany.
          [6 ] University Regensburg, Dept. of Pathology, Germany.
          [7 ] University Tübingen, Dept. of Urology, Germany.
          [8 ] University Tübingen, Dept. of Pathology, Germany.
          [9 ] University Essen, Dept. of Urology, Germany.
          [10 ] University Essen, Dept. of Pathology, Germany.
          [11 ] University RWTH Aachen, Dept. of Urology, Germany.
          [12 ] University RWTH Aachen, Dept. of Pathology, Germany.
          [13 ] University Erlangen, Dept. of Urology, Germany.
          [14 ] University Erlangen, Dept. of Pathology, Germany.
          [15 ] Zentralkrankenhaus Bozen, Dept. of Urology, Bozen, Italy.
          [16 ] Zentralkrankenhaus Bozen, Dept. of Pathology, Bozen, Italy.
          [17 ] Martini-Klinik am UKE, Dept. of Urology, Hamburg-Eppendorf, Germany.
          [18 ] UKE, Dept. of Pathology, Hamburg-Eppendorf, Germany.
          [19 ] University Ulm, Dept. of Radiation Oncology, Germany.
          Article
          S0167-8140(15)00314-X
          10.1016/j.radonc.2015.06.021
          26138059
          fb4b91de-716b-4051-9012-bb214c1ce41f
          History

          Localized prostate cancer,Prognostic parameters,Surgical margins,Adjuvant therapy

          Comments

          Comment on this article